Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome

For more than 10 years, direct oral anticoagulants (DOACs) have been increasingly prescribed for the prevention and treatment of thrombotic events. However, their use in immunothrombotic disorders, namely heparin-induced thrombocytopenia (HIT) and antiphospholipid syndrome (APS), is still under inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Carré, Julie, Jourdi, Georges, Gendron, Nicolas, Helley, Dominique, Gaussem, Pascale, Darnige, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744910/
https://www.ncbi.nlm.nih.gov/pubmed/35008518
http://dx.doi.org/10.3390/ijms23010093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744910/
https://www.ncbi.nlm.nih.gov/pubmed/35008518
http://dx.doi.org/10.3390/ijms23010093

Ejemplares similares